We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOX icon
976
Vanguard Communication Services ETF
VOX
$5.87B
$10.1M 0.01%
107,310
-51,784
-33% -$5.39M
LGI
977
Lazard Global Total Return & Income Fund
LGI
$240M
$10.1M 0.01%
651,575
+14,213
+2% +$229K
BBAG icon
978
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$995M
$10M 0.01%
208,885
-82,284
-28% -$3.99M
ARCC icon
979
Ares Capital
ARCC
$14.4B
$9.99M 0.01%
557,148
+26,673
+5% +$526K
CNMD icon
980
CONMED
CNMD
$1.5B
$9.98M 0.01%
104,253
-930
-0.9% -$112K
TXT icon
981
Textron
TXT
$15.2B
$9.98M 0.01%
163,399
+15,770
+11% +$1.03M
AXON
982
Axon Enterprise
AXON
$51.3B
$9.98M 0.01%
107,082
-1,476
-1% -$156K
DFJ icon
983
WisdomTree Japan SmallCap Dividend Fund
DFJ
$398M
$9.96M 0.01%
167,826
-12,230
-7% -$757K
ENSG icon
984
The Ensign Group
ENSG
$10.6B
$9.94M 0.01%
135,354
+11,466
+9% +$915K
HXL icon
985
Hexcel
HXL
$7.63B
$9.94M 0.01%
190,071
-187
-0.1% -$10.3K
BIO icon
986
Bio-Rad Laboratories Class A
BIO
$9.45B
$9.94M 0.01%
20,082
+1,176
+6% +$612K
AZPN
987
DELISTED
Aspen Technology Inc
AZPN
$9.93M 0.01%
+54,037
New +$9.61M
CALM icon
988
Cal-Maine
CALM
$3.88B
$9.9M 0.01%
200,431
-83,894
-30% -$4.26M
LYV icon
989
Live Nation Entertainment
LYV
$42.9B
$9.9M 0.01%
119,877
-18,332
-13% -$1.76M
NXTG icon
990
First Trust Indxx NextG ETF
NXTG
$564M
$9.88M 0.01%
153,401
-57,500
-27% -$4.01M
FGD icon
991
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.59B
$9.87M 0.01%
453,954
+254,419
+128% +$6.11M
TDS icon
992
Telephone and Data Systems
TDS
$3.89B
$9.86M 0.01%
624,211
-120,239
-16% -$2.15M
DFAT icon
993
Dimensional US Targeted Value ETF
DFAT
$14.8B
$9.84M 0.01%
244,691
-19,808
-7% -$869K
STLD icon
994
Steel Dynamics
STLD
$38B
$9.83M 0.01%
148,582
-27,319
-16% -$2.19M
CENTA icon
995
Central Garden & Pet Co Class A
CENTA
$2.4B
$9.81M 0.01%
306,479
-18,530
-6% -$610K
DELL icon
996
Dell
DELL
$286B
$9.76M 0.01%
211,113
+25,673
+14% +$1.21M
UNF icon
997
Unifirst Corp
UNF
$5.29B
$9.75M 0.01%
56,643
-2,776
-5% -$464K
MLN icon
998
VanEck Long Muni ETF
MLN
$682M
$9.73M 0.01%
550,858
+95,940
+21% +$1.74M
HPQ icon
999
HP
HPQ
$26.6B
$9.71M 0.01%
296,225
-14,960
-5% -$549K
TYL icon
1000
Tyler Technologies
TYL
$13.3B
$9.67M 0.01%
29,075
-44
-0.2% -$16.1K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.